Shafaat A. Rabbani
1001 Decarie Blvd
Montreal, QC H4A3J1, Canada
Montreal, QC H4A3J1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition.
Journal: Experimental & molecular medicine
Published: December 04, 2022
Corrigendum to "Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo" [Neoplasia 10/3 (2008) 266-278].
Journal: Neoplasia (New York, N.Y.)
Published: April 02, 2022
Targeting DNA Hypomethylation in Malignancy by Epigenetic Therapies.
Journal: Advances in experimental medicine and biology
Published: October 03, 2019
DNA methylation signatures of Prostate Cancer in peripheral T-cells.
Journal: BMC cancer
Published: July 12, 2019
DNA methylation signatures of breast cancer in peripheral T-cells.
Journal: BMC cancer
Published: September 06, 2017
SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis.
Journal: Molecular cancer therapeutics
Published: April 29, 2010
An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo.
Journal: Neoplasia (New York, N.Y.)
Published: February 18, 2010
Evaluating distant metastases in breast cancer: from biology to outcomes.
Journal: Cancer metastasis reviews
Published: September 08, 2007
Showing 1-10 of 10
Last Updated: 09/26/2026